# 225 Phase 3 Carry-Forward Boundary

This boundary preserves the approved patient/support baseline while making the next work explicit.

## Non-Reopening Laws

Phase 3 and later release work may extend the baseline, but they may not reopen these already-approved truths without an explicit future change record:

1. patient and support routes consume the same Phase 2 identity, status, capability, and recovery truth
2. same-shell continuity and typed return bundles remain mandatory across patient and support route families
3. support replay, observe, mask scope, and read-only fallback preserve chronology and fail closed in place
4. record artifacts and communication artifacts remain parity-safe and restriction-safe
5. support remains a governed ticket surface and may not become a second system of record

## Carry-Forward Items

| Item | Next owner | Carry-forward class | Blocking class | Why this is not an exit blocker |
| --- | --- | --- | --- | --- |
| Freeze the Phase 3 triage workspace state model and route-command contract pack | `seq_226` | phase3_contract_publication | phase3_entry_dependency_non_blocking | This exit gate approves the current patient/support baseline only. Queue-task workspace contracts are explicitly the next publication step rather than part of the already-approved route family. |
| Freeze queue ranking, fairness, duplicate-cluster, and more-info review contracts | `seq_227` | phase3_contract_publication | phase3_entry_dependency_non_blocking | The current baseline does not expose Phase 3 queue ranking or duplicate review as live human-checkpoint routes. Those capabilities extend the approved baseline; they do not define it. |
| Freeze endpoint decision, approval, escalation, callback, and admin-resolution boundaries | `seq_228_to_seq_229` | phase3_contract_publication | phase3_follow_on_non_blocking | Those mutable human-checkpoint decisions are downstream of the already-approved patient/support baseline. They must consume this baseline rather than hold it open. |
| Replay the baseline against credentialled live environments and provider bindings | `future_production_release_gate` | future_live_boundary | live_environment_boundary_non_blocking | The 225 verdict explicitly approves the repository-runnable baseline, not live-provider operation. Live replay remains outside the current gate by design. |
| Obtain production clinical-safety, DSPT, rollback, and operational signoff | `future_production_release_gate` | future_live_boundary | production_assurance_non_blocking | This gate is a product-baseline gate for the patient/support family. Production release approval remains a distinct governance boundary and is intentionally not claimed here. |

## Boundary Interpretation

- Items owned by `seq_226` through `seq_229` are Phase 3 contract-publication and implementation prerequisites, not defects in the current baseline.
- Items owned by the future production release gate remain outside this approval by design and must stay outside until re-proven in credentialled live environments.
